BSX vs IVF · P/E 20, rev $10.65B vs rev $2.2M
Boston Scientific Corp (BSX) versus INVO Fertility, Inc. (IVF) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
INVO Fertility, Inc. (IVF) is a medical devices company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported IVF revenue for 2026-06-30 was $2.2M. Net income was $888.7K. Revenue was up 8.0% from 2026-03-31 to 2026-06-30. IVF currently screens at market cap $2.8M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. IVF currently screens at market cap $2.8M.
Not investment advice. Open the BSX and IVF stock pages for the full models.
Not investment advice.